+ All Categories
Home > Documents > PULMONARY: ASTHMA AND COPD Two conditions. One problem. · Care Cost PULMONARY: ASTHMA AND COPD...

PULMONARY: ASTHMA AND COPD Two conditions. One problem. · Care Cost PULMONARY: ASTHMA AND COPD...

Date post: 08-Aug-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
1
Cost Care Care PULMONARY: ASTHMA AND COPD Many patients and caregivers struggle with the complexities of these conditions. Our Pulmonary Care Value Program SM (PCV) helps your members who are being treated for asthma or COPD. This program takes a holistic approach to patient health that pushes the boundaries of patient care while driving lower healthcare costs for payers. Another powerful solution in the Express Scripts SafeGuardRx ® suite | express-scripts.com/corporate 1 National Heart, Lung, and Blood Institue. 2 2016 Express Scripts Drug Trend Report. 3 American Academy of Allergy Asthma & Immunology. 4 The Mayo Clinic. 5 Truven Analytics Redbook ® on drug pricing. 6 Express Scripts book of business. © 2016 Express Scripts Holding Company. All Rights Reserved. 16EME36574 3rd leading cause of death in our country 1 Asthma COPD 3rd leading cause of hospital stays in children 3 Progressive disease that makes it hard to breathe 1 Respiratory condition that makes it hard to breathe 3 The major factors hindering care Without better adherence, expenses will continue to soar Growing population Poor adherence aren’t taking their medication correctly 2 75 % Lack of education don’t know how to avoid triggers that can cause difficulty breathing 2 > 50 % in the U.S. have asthma or COPD 1 37M Current costs Nonadherence impact increased total healthcare costs due to pulmonary nonadherence $ 138M Opportunities better adherence when patients fill 90-day supplies 6 13 % Annual asthma and COPD prescription costs in the U.S. 6 $ 1.3B Two conditions. One problem. The problem? Nonadherence. Adherence is key to preventing and controlling symptoms of both asthma and COPD. Americans 1 Americans 3 Tobacco smoke, occupational dust, fumes and genetic factors 4 over age 45 1 under age 18 3 25M 16M 70 % 25 % Genetic condition exacerbated by environmental conditions, pet dander and respiratory infections 3 Who Risks What Impact Causes
Transcript
Page 1: PULMONARY: ASTHMA AND COPD Two conditions. One problem. · Care Cost PULMONARY: ASTHMA AND COPD Many patients and caregivers struggle with the complexities of these conditions. Our

CostCareCare

PULMONARY: ASTHMA AND COPDMany patients and caregivers struggle with the complexities of these conditions.

Our Pulmonary Care Value ProgramSM (PCV) helps your members who are being treated for asthma or COPD. This program takes a holistic approach to patient health that pushes the boundaries of patient care while driving lower healthcare costs for payers.Another powerful solution in the Express Scripts SafeGuardRx® suite | express-scripts.com/corporate

1 National Heart, Lung, and Blood Institue. 2 2016 Express Scripts Drug Trend Report. 3 American Academy of Allergy Asthma & Immunology. 4 The Mayo Clinic. 5 Truven Analytics Redbook® on drug pricing. 6 Express Scripts book of business.

© 2

01

6 E

xpre

ss S

crip

ts H

oldi

ng C

ompa

ny.

All

Rig

hts

Res

erve

d. 1

6E

ME

36

57

4

3rd leading cause of death in our country1

Asthma COPD

3rd leading cause of hospital stays in children3

Progressive disease that makes it hard

to breathe1

Respiratory condition that makes it hard

to breathe3

The major factors hindering care

Without better adherence, expenses will continue

to soar

Growing population

Poor adherence

aren’t taking their medication correctly2

75%

Lack of education

don’t know how to avoid triggers that can cause difficulty breathing2

>50%

in the U.S. have asthma or COPD1

37MCurrent costs

Nonadherence impact

increased total healthcare costs due to pulmonary

nonadherence

$138M

Opportunities

better adherence when patients fill 90-day supplies6

13%

Annual asthma and COPD prescription costs

in the U.S.6

$1.3B

Two conditions. One problem.The problem? Nonadherence.Adherence is key to preventing and controlling symptoms

of both asthma and COPD.

Americans1Americans3

Tobacco smoke, occupational dust, fumes

and genetic factors4

over age 451under age 183

25M 16M

70% 25%

Genetic condition exacerbated by

environmental conditions, pet dander and respiratory

infections3

Who

Risks

What

Impact

Causes

Recommended